Please select the option that best describes you:
Topics:
Medical Oncology • Internal Medicine • Rheumatology • Hematology • General Rheumatology • VEXAS
For patients with VEXAS syndrome and good response to azacitidine, what duration of therapy do you consider?
How do you decide to trial a patient off treatment? When do you consider spacing therapy and at what frequency?